title: [The role of radiotherapy in endocrine orbitopathy].
abstract: The treatment of Graves' ophthalmopathy is symptomatic because the etiology remains unknown though evidence supports an aberrant immune response. Orbital radiotherapy, combined with corticosteroids, is indicated for rapidly progressive ophthalmopathy and troublesome soft tissue symptoms. In case of sight-threatening manifestations operative decompression is the method of choice. However, radiotherapy seems to be a safe and effective method as a good to excellent response in 60-70% of patients can be expected. The treatment results of 15 patients with a long term follow-up are presented.
authors: Klinik und Poliklinik für Strahlentherapie Universität Würzburg.
authors: T
authors: T
authors: Feyerabend
authors: E
authors: E
authors: Richter
authors: W
authors: W
authors: Buschmann
authors: W
authors: W
authors: Becker
authors: M
authors: M
authors: Herbolsheimer
authors: B
authors: B
authors: Pingel
mesh_terms: D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006111:Graves Disease / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009801:Oculomotor Muscles / Q000528:radiation effects; D009915:Orbit / Q000528:radiation effects*; D011832:Radiation Injuries / Q000000981:diagnostic imaging; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D014057:Tomography, X-Ray Computed
chemical_list: D003037:Cobalt Radioisotopes
vernacular_title: Die Rolle der Strahlentherapie bei der endokrinen Orbitopathie.